CA
NZ
UK
AU
IND
US
Spero Therapeutics, Inc. (NASDAQ: SPRO) has signed a licensing arrangement with Innovent that grants rights to develop and eventually market a CD40L‑directed monoclonal antibody, designated SP001. The deal expands Spero’s portfolio of immunology assets and aligns with its strategy to bring novel biologics to …
Payment technology giant Visa is drawing fresh bullish attention from Wall Street as analysts raise price targets and project stronger earnings growth. The moves signal confidence in the company’s ability to sustain revenue momentum despite near-term headwinds, lifting sentiment across the broader digital payments …
Stifel Financial Corp. (NYSE: SF) released an analyst brief that linked the $400M defense award awarded to Kratos with a forward‑looking upside for Rocket Lab. The comment sparked a modest rally in SF equity, underscoring investor interest in the defense‑linked growth storyline.
The S&P 500 rose 0.4%, while the Nasdaq Composite gained 1%. The Dow Jones Industrial Average slipped by less than 0.1%. The report suggests that inflation may be cooling down, which could impact the Federal Reserve's decision.
VNV Global AB delivered a second‑quarter update that showed a steady net asset value, yet the company’s shares continued to trade at a sizable discount of 53% to NAV. The data point signals ongoing valuation challenges for listed investment trusts, prompting caution among market …
SUI Group Holdings Ltd. (NASDAQ: SUIG) disclosed a senior management change that may influence its investment strategy. Stephen Mackintosh, the firm’s Chief Investment Officer, notified the board of his intent to resign, with the exit taking effect on July 8, 2026.
Datavault AI Inc. (NASDAQ: DVLT) has appointed CBIZ CPAs as its new independent auditor for the fiscal year ending December 31, as disclosed in a recent regulatory filing. The decision reflects the company’s preparations for its financial reporting obligations in the coming period.
Federal Home Loan Bank of Indianapolis disclosed a governance shift as its board chair indicated he will not contest the upcoming 2027 director election. The announcement, filed on Jul 13 2026, underscores a routine leadership transition within the institution.
IGC Pharma, Inc. (NYSE American: IGC) disclosed that it has refreshed its investor presentation, positioning the material for outreach to investors, analysts, and potential strategic collaborators. The update reflects the latest corporate and clinical information available as of the filing date.
Galaxy Digital Inc. (TSX: GLXY) has appointed Steven Bandrowczak as a director, effective July 13, 2026, to serve on the board and audit committee. This move is expected to bring significant financial expertise to the company. Bandrowczak's experience in the financial sector will be …
Please wait processing your request...